J
James A. Ferretti
Researcher at National Institutes of Health
Publications - 87
Citations - 2171
James A. Ferretti is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Circular dichroism & Mutant. The author has an hindex of 25, co-authored 87 publications receiving 2131 citations. Previous affiliations of James A. Ferretti include Fox Chase Cancer Center.
Papers
More filters
Journal ArticleDOI
Selection of optimum parameters for pulse Fourier transform nuclear magnetic resonance
Journal ArticleDOI
Rapid scan Fourier transform NMR spectroscopy
TL;DR: In this paper, the theoretical basis for the use of cross correlation to extract an undistorted spectrum from a rapid scan response (as first suggested by Dadok) is examined in detail.
Journal ArticleDOI
In vivo flux between phosphocreatine and adenosine triphosphate determined by two-dimensional phosphorous NMR.
TL;DR: The in vivo unidirectional flux between creatine phosphate and ATP was determined in the leg and head of the anesthetized rat using a two-dimensional NMR technique and was estimated to be less than 0.1 mumol/s/g-weight.
Journal ArticleDOI
The choice of optimal parameters for measurement of spin-lattice relaxation times. II. Comparison of saturation recovery, inversion recovery, and fast inversion recovery experiments
TL;DR: In this article, the authors compared the performance of saturation recovery, inversion recovery, fast inversion, and Freeman-Hill techniques for the measurement of spin-lattice relaxation times, T1, for conditions of ideal 90° and 180° pulses.
Journal ArticleDOI
Expression studies and mutational analysis of the androgen regulated homeobox gene nkx3.1 in benign and malignant prostate epithelium
David K. Ornstein,Mario Cinquanta,Solly Weiler,Paul H. Duray,Michael R. Emmert-Buck,Cathy D. Vocke,W. Marston Linehan,James A. Ferretti +7 more
TL;DR: It is demonstrated that in human prostates NKX3.1 was expressed in all grades of malignant epithelium in all 25 cases examined and does not appear to be a classic tumor suppressor gene responsible for prostate cancer initiation, which is consistent with the role of NKX 3.1 in the development of normal prostate epithelia and maintenance of normal secretory function.